Come up with a name for your new list and we'll add to it:
Enlyton raised a round of funding on January 05, 2018. Investors include
East Sunshine Foresight Fund.
Enlyton is integrating proprietary antibody technology into cancer-specific, antigen-directed targeting agents for use in cancer imaging, intraoperative cancer detection, and post-operative disease pr…